Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Ueber die Wirkung des Alloxans beim Kaninchen.

AUFDERMAUR M.

Schweiz Z Pathol Bakteriol. 1948;11(1):42-53. Undetermined Language. No abstract available.

PMID:
18904883
2.

Alloxan diabetes.

LUKENS FD.

Physiol Rev. 1948 Jul;28(3):304-30. No abstract available.

3.
4.

Differentiation of two types of basophils in the adenohypophysis of the rat and the mouse.

HALMI NS.

Stain Technol. 1952 Jan;27(1):61-4. No abstract available.

PMID:
14931079
5.

Diabetes-induced biochemical changes in central and peripheral catecholaminergic systems.

Gallego M, Setién R, Izquierdo MJ, Casis O, Casis E.

Physiol Res. 2003;52(6):735-41.

6.

Diabetes & coronary artery disease.

Arvind K, Pradeepa R, Deepa R, Mohan V.

Indian J Med Res. 2002 Nov;116:163-76. Review.

PMID:
12710546
7.

Diabetes activates cell death pathway after transient focal cerebral ischemia.

Muranyi M, Fujioka M, He Q, Han A, Yong G, Csiszar K, Li PA.

Diabetes. 2003 Feb;52(2):481-6.

8.
9.

Biochemistry and molecular cell biology of diabetic complications.

Brownlee M.

Nature. 2001 Dec 13;414(6865):813-20.

PMID:
11742414
10.

Administration of NF-kappaB decoy inhibits pancreatic activation of NF-kappaB and prevents diabetogenesis by alloxan in mice.

Quan N, Ho E, La W, Tsai YH, Bray T.

FASEB J. 2001 Jul;15(9):1616-8. No abstract available.

PMID:
11427504
11.

Cellular and clinical implications of glutathione.

Gul M, Kutay FZ, Temocin S, Hanninen O.

Indian J Exp Biol. 2000 Jul;38(7):625-34. Review. No abstract available.

PMID:
11215303
12.

Decreased apoptosis as a mechanism for hepatomegaly in streptozotocin-induced diabetic rats.

Herrman CE, Sanders RA, Klaunig JE, Schwarz LR, Watkins JB 3rd.

Toxicol Sci. 1999 Jul;50(1):146-51.

PMID:
10445763
13.

Reducing the burden of diabetes: managing cardiovascular disease.

Keen H, Clark C, Laakso M.

Diabetes Metab Res Rev. 1999 May-Jun;15(3):186-96. Review.

PMID:
10441041
14.

Alloxan in vivo does not only exert deleterious effects on pancreatic B cells.

Szkudelski T, Kandulska K, Okulicz M.

Physiol Res. 1998;47(5):343-6.

15.

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M.

N Engl J Med. 1998 Jul 9;339(2):69-75.

16.

Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.

Yabe-Nishimura C.

Pharmacol Rev. 1998 Mar;50(1):21-33. Review. No abstract available.

17.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

[No authors listed]

Diabetes Care. 1997 Jul;20(7):1183-97. No abstract available.

PMID:
9203460
18.

Effects of experimental diabetes and insulin on smooth muscle functions.

Oztürk Y, Altan VM, Yildizoğlu-Ari N.

Pharmacol Rev. 1996 Mar;48(1):69-112. Review. No abstract available.

PMID:
8685248
19.
20.

Diabetes complications: why is glucose potentially toxic?

Porte D Jr, Schwartz MW.

Science. 1996 May 3;272(5262):699-700. Review. No abstract available. Erratum in: Science 1996 Jun 28;272(5270):1861.

PMID:
8614830

Supplemental Content

Support Center